Questcor Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference PR Newswire ANAHEIM, Calif., Jan. 8, 2014 ANAHEIM, Calif., Jan. 8, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that Don Bailey, the Company's President and Chief Executive Officer, will present at the J.P. Morgan Healthcare Conference in San Francisco on January 16, 2014 at 9:00 AM PT/12:00 PM ET. A live webcast and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm. The replay will be available for approximately 90 days after the event. About Questcor Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Questcor also provides specialty contract manufacturing services to the global pharmaceutical industry through its wholly-owned subsidiary BioVectra Inc. For more information about Questcor, please visit www.questcor.com. SOURCE Questcor Pharmaceuticals, Inc. Website: http://www.questcor.com Contact: EVC Group, Gregory Gin/Patty Eisenhaur, 646-445-4801/951-316-0577, Janine McCargo, 646-688-0425
Questcor Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.